These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 36364196)

  • 1. Progression of Antiviral Agents Targeting Viral Polymerases.
    Peng S; Wang H; Wang Z; Wang Q
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral therapy targeting viral polymerase.
    Tsai CH; Lee PY; Stollar V; Li ML
    Curr Pharm Des; 2006; 12(11):1339-55. PubMed ID: 16611119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
    Magee WC; Evans DH
    Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of polymerase inhibitors as antiviral drugs.
    Oberg B
    Antiviral Res; 2006 Sep; 71(2-3):90-5. PubMed ID: 16820225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of antivirals: broad-spectrum inhibitors.
    Debing Y; Neyts J; Delang L
    Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An all-atom, active site exploration of antiviral drugs that target Flaviviridae polymerases.
    Valdés JJ; Gil VA; Butterill PT; Růžek D
    J Gen Virol; 2016 Oct; 97(10):2552-2565. PubMed ID: 27489039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus.
    Deval J; Symons JA; Beigelman L
    Curr Opin Virol; 2014 Dec; 9():1-7. PubMed ID: 25194816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.
    Furuta Y; Komeno T; Nakamura T
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):449-463. PubMed ID: 28769016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An RNA Hybridization Assay for Screening Influenza A Virus Polymerase Inhibitors Using the Entire Ribonucleoprotein Complex.
    Roch FF; Hinterkörner G; Menke J; Tang GQ; Cusack S; Butzendobler B; Buschmann H; Datta K; Wolkerstorfer A
    Assay Drug Dev Technol; 2015 Oct; 13(8):488-506. PubMed ID: 26461433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor.
    Xiong H; Foulk M; Aschenbrenner L; Fan J; Tiong-Yip CL; Johnson KD; Moustakas D; Fleming PR; Brown DG; Zhang M; Ferguson D; Wu D; Yu Q
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6789-93. PubMed ID: 24211022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
    Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
    J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic and nonenzymatic functions of viral RNA-dependent RNA polymerases within oligomeric arrays.
    Spagnolo JF; Rossignol E; Bullitt E; Kirkegaard K
    RNA; 2010 Feb; 16(2):382-93. PubMed ID: 20051491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate.
    Deval J; Hong J; Wang G; Taylor J; Smith LK; Fung A; Stevens SK; Liu H; Jin Z; Dyatkina N; Prhavc M; Stoycheva AD; Serebryany V; Liu J; Smith DB; Tam Y; Zhang Q; Moore ML; Fearns R; Chanda SM; Blatt LM; Symons JA; Beigelman L
    PLoS Pathog; 2015 Jun; 11(6):e1004995. PubMed ID: 26098424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favipiravir (T-705), a novel viral RNA polymerase inhibitor.
    Furuta Y; Gowen BB; Takahashi K; Shiraki K; Smee DF; Barnard DL
    Antiviral Res; 2013 Nov; 100(2):446-54. PubMed ID: 24084488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase.
    Fearns R; Deval J
    Antiviral Res; 2016 Oct; 134():63-76. PubMed ID: 27575793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
    Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV RNA-dependent RNA polymerase as a target for antiviral development.
    Walker MP; Hong Z
    Curr Opin Pharmacol; 2002 Oct; 2(5):534-40. PubMed ID: 12324255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review on the Progress and Prospects of Dengue Drug Discovery Targeting NS5 RNA- Dependent RNA Polymerase.
    Maddipati VC; Mittal L; Mantipally M; Asthana S; Bhattacharyya S; Gundla R
    Curr Pharm Des; 2020; 26(35):4386-4409. PubMed ID: 32445444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.